rs6749826
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_032208.3(ANTXR1):c.1185+16C>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.457 in 1,611,934 control chromosomes in the GnomAD database, including 174,406 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.47 ( 17232 hom., cov: 31)
Exomes 𝑓: 0.46 ( 157174 hom. )
Consequence
ANTXR1
NM_032208.3 intron
NM_032208.3 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.406
Genes affected
ANTXR1 (HGNC:21014): (ANTXR cell adhesion molecule 1) This gene encodes a type I transmembrane protein and is a tumor-specific endothelial marker that has been implicated in colorectal cancer. The encoded protein has been shown to also be a docking protein or receptor for Bacillus anthracis toxin, the causative agent of the disease, anthrax. The binding of the protective antigen (PA) component, of the tripartite anthrax toxin, to this receptor protein mediates delivery of toxin components to the cytosol of cells. Once inside the cell, the other two components of anthrax toxin, edema factor (EF) and lethal factor (LF) disrupt normal cellular processes. Three alternatively spliced variants that encode different protein isoforms have been described. [provided by RefSeq, Oct 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BP6
Variant 2-69181897-C-A is Benign according to our data. Variant chr2-69181897-C-A is described in ClinVar as [Benign]. Clinvar id is 262019.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-69181897-C-A is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.747 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.467 AC: 70909AN: 151766Hom.: 17228 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
70909
AN:
151766
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.481 AC: 120775AN: 251062 AF XY: 0.487 show subpopulations
GnomAD2 exomes
AF:
AC:
120775
AN:
251062
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.456 AC: 665263AN: 1460048Hom.: 157174 Cov.: 32 AF XY: 0.461 AC XY: 335229AN XY: 726450 show subpopulations
GnomAD4 exome
AF:
AC:
665263
AN:
1460048
Hom.:
Cov.:
32
AF XY:
AC XY:
335229
AN XY:
726450
Gnomad4 AFR exome
AF:
AC:
17337
AN:
33442
Gnomad4 AMR exome
AF:
AC:
21157
AN:
44704
Gnomad4 ASJ exome
AF:
AC:
11039
AN:
26116
Gnomad4 EAS exome
AF:
AC:
30988
AN:
39688
Gnomad4 SAS exome
AF:
AC:
56701
AN:
86186
Gnomad4 FIN exome
AF:
AC:
16092
AN:
53370
Gnomad4 NFE exome
AF:
AC:
479878
AN:
1110460
Gnomad4 Remaining exome
AF:
AC:
28851
AN:
60320
Heterozygous variant carriers
0
17432
34863
52295
69726
87158
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
14972
29944
44916
59888
74860
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.467 AC: 70950AN: 151886Hom.: 17232 Cov.: 31 AF XY: 0.467 AC XY: 34695AN XY: 74220 show subpopulations
GnomAD4 genome
AF:
AC:
70950
AN:
151886
Hom.:
Cov.:
31
AF XY:
AC XY:
34695
AN XY:
74220
Gnomad4 AFR
AF:
AC:
0.508241
AN:
0.508241
Gnomad4 AMR
AF:
AC:
0.486692
AN:
0.486692
Gnomad4 ASJ
AF:
AC:
0.422344
AN:
0.422344
Gnomad4 EAS
AF:
AC:
0.767352
AN:
0.767352
Gnomad4 SAS
AF:
AC:
0.672292
AN:
0.672292
Gnomad4 FIN
AF:
AC:
0.296219
AN:
0.296219
Gnomad4 NFE
AF:
AC:
0.429335
AN:
0.429335
Gnomad4 OTH
AF:
AC:
0.479563
AN:
0.479563
Heterozygous variant carriers
0
1873
3746
5618
7491
9364
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
648
1296
1944
2592
3240
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2251
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
May 10, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Capillary infantile hemangioma Benign:1
Jul 07, 2023
KCCC/NGS Laboratory, Kuwait Cancer Control Center
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
GAPO syndrome Benign:1
Jul 14, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
Mutation Taster
=100/0
polymorphism (auto)
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at